Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY.

Bio Med has successfully developed its IPN technology into the Silon, Oleeva and SeaAllure lines of products. The company sells direct to patients, consumers and clinical practices as well as through distributors. Silon products are available exclusively from Bio Med Sciences and through authorized business partners.

AiViva BioPharma, Inc. is a privately held clinical-stage biotech company that is developing revolutionary technologies to meet unmet medical needs by converting current medicines to generate localized, targeted disease treatment while reducing systemic exposure. Their expertise includes the creation of pharmaceuticals in the specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology utilizing their unique JELTM Technology. They are developing formulations, oncology, dermatology, ophthalmology, clinical, and delivery formulations.

Guangzhou Institutes of Biomedicine and Health (GIBH)，(simplified Chinese: 中国科学院广州生物医药与健康研究院; traditional Chinese: 中國科學院廣州生物醫藥與健康研究院; pinyin: Zhōngguó Kēxué yuan guangzhou sheng wu yi yao yu jian kang yan jiu yuan) affiliated with the Chinese Academy of Sciences, is a government-sponsored scientific research institution with independent legal jurisdiction. GIBH was established by the Chinese Academy of Sciences, Guangdong Provincial Government and Guangzhou Municipal Government. The managerial mechanism of GIBH is the responsibility of Director-General, under the authority of the board of trustees.

Moerae Matrix is a privately held biopharmaceutical company focused on the development of first-in-class targeted therapeutics for fibrotic diseases.

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Canji, Inc., part of Merck & Co., Inc., is a company headquartered in San Diego, CA, specializing in medical laboratories. Schering-Plough Corp., now part of Merck & Co., Inc. acquired Canji, Inc. on February 02, 1996 for $54.50 million.

Shenyang Hongda Information Technology Co., Ltd., established on 2012-11-14, Business scope includes licensed business items:No general operating items:Research and development of electronic information technology and mechanical automation technology,Economic Information Consulting,Investment Project Consulting,Business Management Consulting,Business Economic Agency Service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. It operates through the following segments: Pharmaceuticals and Limulus Amebocyte Lysate (LAL). The Pharmaceuticals segment develops and supplies intra-articular injections for improving joint functions, cross-linked hyaluronate hydrogel for knee osteoarthritis, opthalmic surgical aids, and surgical aids for endoscopic mucosal resection. The LAL segment manufactures and sells endotoxin-detecting reagents in Japan and overseas. The company was founded on June 2, 1947 and is headquartered in Tokyo, Japan.

Isolagen Technologies, Inc. researches and develops cellular technology. specializes in the development and commercialization of autologous cellular system. The company is headquartered in Houston, TX.

Haikou Pharmaceutical Factory Co., Ltd., established on 1990-03-09, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Import and export;Technology Import and Export;Drug import and export;Drug Wholesale;Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Non-residential real estate leases;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;property management;Chemical product sales(No licensed chemical products);Sales of Class II Medical Devices(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Zhejiang Cnb Health Products Co., Ltd. is a company headquartered in Hangzhou, China, that operates as a biotechnology company.

Guangdong General Hospital (Chinese: 广东省人民医院 meaning "Guangdong Provincial People's Hospital") is a large hospital, founded in 1946, located in Yuexiu District, Guangzhou, Guangdong, China.

Shanghai Meibo Life Technology Co., Ltd., established on 2002-11-26, Business scope includes licensed projects:Class III medical device business;Production of Class III Medical Devices;Production of Class II Medical Devices;Cosmetic production;Production of hygiene products and single-use medical products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Import and export;Cosmetics Wholesale;internet sales(Except for products that require a license for sale);Cosmetics Retail;Sales of hygiene products and single-use medical products;Sales of Class I Medical Devices;Manufacturing of daily chemical products;Sales of Class II Medical Devices;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France.

Anshan Iron & Steel Group Corp. engages in the manufacture and sale of iron and steel products. Its business includes sintering, pelletizing, iron making, steel making, rolling steel comprehensive support, coking, fire resistance, power, transportation, and technology research and development. Its products includes hot rolled sheet, cold rolled sheet, galvanized sheet, color coated sheet, cold rolled silicon steel, heavy rail, seamless steel tube, and building materials. Its products are used in state defense, ship, marine engineering, bridge, automobile nuclear power railways, home appliances, and energy. The company was founded on December 26, 1948 and is headquartered in Anshan, China.